| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | signaling adaptor activity | 5.25e-05 | 129 | 102 | 6 | GO:0035591 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | APPBP2 RNF169 TCOF1 NOC2L PEX1 IRAK2 ICE1 BTAF1 AKAP12 MAPK8IP3 IFNAR2 FXR1 GAB4 LPXN LPIN2 AKAP13 MPHOSPH8 | 7.67e-05 | 1160 | 102 | 17 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | APPBP2 RNF169 TCOF1 NOC2L PEX1 IRAK2 ICE1 BTAF1 AKAP12 MAPK8IP3 IFNAR2 FXR1 GAB4 LPXN LPIN2 AKAP13 MPHOSPH8 PCM1 | 1.62e-04 | 1356 | 102 | 18 | GO:0060090 |
| GeneOntologyCellularComponent | centriole | 2.78e-05 | 172 | 106 | 7 | GO:0005814 | |
| Domain | Cordon-bleu_ubiquitin_domain | 3.01e-05 | 2 | 103 | 2 | IPR019025 | |
| Domain | Cobl | 3.01e-05 | 2 | 103 | 2 | PF09469 | |
| Domain | RII_binding_1 | 2.98e-04 | 5 | 103 | 2 | PF10522 | |
| Domain | RII_binding_1 | 2.98e-04 | 5 | 103 | 2 | IPR018459 | |
| Domain | Znf_FYVE_PHD | 1.33e-03 | 147 | 103 | 5 | IPR011011 | |
| Domain | BROMODOMAIN_2 | 1.49e-03 | 41 | 103 | 3 | PS50014 | |
| Domain | BROMO | 1.60e-03 | 42 | 103 | 3 | SM00297 | |
| Domain | Bromodomain | 1.60e-03 | 42 | 103 | 3 | IPR001487 | |
| Domain | - | 1.60e-03 | 42 | 103 | 3 | 1.20.920.10 | |
| Domain | PH | 1.69e-03 | 229 | 103 | 6 | PF00169 | |
| Domain | VitD_rcpt | 2.62e-03 | 14 | 103 | 2 | IPR000324 | |
| Domain | OAR | 3.02e-03 | 15 | 103 | 2 | PF03826 | |
| Domain | OAR | 3.44e-03 | 16 | 103 | 2 | PS50803 | |
| Domain | WH2 | 3.44e-03 | 16 | 103 | 2 | PF02205 | |
| Domain | OAR_dom | 3.44e-03 | 16 | 103 | 2 | IPR003654 | |
| Domain | PH | 4.42e-03 | 278 | 103 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 4.50e-03 | 279 | 103 | 6 | PS50003 | |
| Domain | PH_domain | 4.57e-03 | 280 | 103 | 6 | IPR001849 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 TTC28 COBLL1 BRCC3 FRYL INPP5F CEP170 FXR1 DLC1 ALMS1 OSBPL3 KMT2A COBL NHS AKAP13 WNK4 EDRF1 PCM1 SPATA13 | 1.47e-11 | 861 | 106 | 19 | 36931259 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PDS5B NR2C2 RNF169 MIS18BP1 LCORL BTAF1 BPTF GTF3C1 PITX1 FAM169A KMT2A MPHOSPH8 SENP7 | 4.52e-08 | 608 | 106 | 13 | 36089195 |
| Pubmed | NR2C2 TTC28 LCORL GEMIN5 ICE1 INPP5F BIRC6 GTF3C1 ALMS1 ZFHX4 PCM1 | 6.63e-08 | 418 | 106 | 11 | 34709266 | |
| Pubmed | PDS5B TCOF1 NOC2L GEMIN5 FRYL BIRC6 CEP170 BPTF FXR1 GTF3C1 UTP25 KMT2A PCM1 | 1.03e-07 | 653 | 106 | 13 | 22586326 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TCEA1 PDS5B RNF169 TCOF1 GEMIN5 BTAF1 MAPK8IP3 BPTF GTF3C1 ZNF335 EIF4G2 KMT2A MN1 PCM1 | 1.04e-07 | 774 | 106 | 14 | 15302935 |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 1.30e-07 | 265 | 106 | 9 | 19240061 | |
| Pubmed | TCEA1 PDS5B TTC28 NOC2L BIRC6 BPTF FXR1 GTF3C1 ALMS1 KMT2A VDR | 2.10e-07 | 469 | 106 | 11 | 27634302 | |
| Pubmed | TCEA1 RNF169 MIS18BP1 TTC28 CEP170 ALMS1 FAM169A KMT2A SLBP MPHOSPH8 EDRF1 PCM1 | 6.74e-07 | 645 | 106 | 12 | 25281560 | |
| Pubmed | 7.38e-07 | 102 | 106 | 6 | 10231032 | ||
| Pubmed | DCDC1 TTC28 TCOF1 PEX1 SP110 CEP170 BPTF FXR1 ALMS1 ZFHX4 UTP25 ZNF827 OSBPL3 PCM1 SENP7 | 1.52e-06 | 1116 | 106 | 15 | 31753913 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | RALGAPA1 NOC2L RABL2B RABL2A FXR1 GTF3C1 GPR158 EIF4G2 WNK4 PCM1 | 1.59e-06 | 462 | 106 | 10 | 31138677 |
| Pubmed | 4.55e-06 | 407 | 106 | 9 | 12693553 | ||
| Pubmed | The CEP19-RABL2 GTPase Complex Binds IFT-B to Initiate Intraflagellar Transport at the Ciliary Base. | 5.93e-06 | 12 | 106 | 3 | 28625565 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RIN3 GEMIN5 FYCO1 FRYL ICE1 BTAF1 BIRC6 MAPK8IP3 ZNF827 ZNF335 PITX1 COBL AKAP13 SPATA13 | 6.87e-06 | 1105 | 106 | 14 | 35748872 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 8.51e-06 | 440 | 106 | 9 | 34244565 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17854671 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27732084 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25356636 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20138207 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10444334 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 33075816 | ||
| Pubmed | AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner. | 9.20e-06 | 2 | 106 | 2 | 16061630 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15326615 | ||
| Pubmed | RABL2 positively controls localization of GPCRs in mammalian primary cilia. | 9.20e-06 | 2 | 106 | 2 | 30578315 | |
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | 1.12e-05 | 247 | 106 | 7 | 32989298 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 MBP TRIOBP FRYL BTAF1 EIPR1 MAPK8IP3 CEP170 BPTF GTF3C1 ZNF827 GPR158 COBL AKAP13 ANKRD12 PCM1 | 1.14e-05 | 1489 | 106 | 16 | 28611215 |
| Pubmed | 2.09e-05 | 493 | 106 | 9 | 15368895 | ||
| Pubmed | Does 3D Phenotyping Yield Substantial Insights in the Genetics of the Mouse Mandible Shape? | 2.17e-05 | 18 | 106 | 3 | 26921296 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 33809261 | ||
| Pubmed | Menin is necessary for long term maintenance of meningioma-1 driven leukemia. | 2.76e-05 | 3 | 106 | 2 | 33542482 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 37361896 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 37480305 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 18195096 | ||
| Pubmed | Cordon-bleu is a conserved gene involved in neural tube formation. | 2.76e-05 | 3 | 106 | 2 | 14512015 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 3.45e-05 | 120 | 106 | 5 | 31413325 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TCEA1 PDS5B NR2C2 RNF169 ICE1 CEP170 BPTF EIF4G2 KMT2A MPHOSPH8 SLX4 PCM1 | 3.51e-05 | 954 | 106 | 12 | 36373674 |
| Pubmed | 4.82e-05 | 549 | 106 | 9 | 38280479 | ||
| Pubmed | MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia. | 5.50e-05 | 4 | 106 | 2 | 26927674 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 11567631 | ||
| Pubmed | 6.92e-05 | 446 | 106 | 8 | 24255178 | ||
| Pubmed | 7.71e-05 | 453 | 106 | 8 | 29656893 | ||
| Pubmed | RALGAPA1 RNF169 TTC28 ICE1 BIRC6 CEP170 FXR1 ALMS1 AKAP13 PCM1 | 8.41e-05 | 733 | 106 | 10 | 34672954 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 8.70e-05 | 341 | 106 | 7 | 32971831 | |
| Pubmed | Rabl2 GTP hydrolysis licenses BBSome-mediated export to fine-tune ciliary signaling. | 9.15e-05 | 5 | 106 | 2 | 33241915 | |
| Pubmed | Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination. | 9.15e-05 | 5 | 106 | 2 | 31866999 | |
| Pubmed | FGF23 promotes renal calcium reabsorption through the TRPV5 channel. | 9.15e-05 | 5 | 106 | 2 | 24434184 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 26329759 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 23361013 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.04e-04 | 351 | 106 | 7 | 38297188 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | NR2C2 MIS18BP1 LCORL NPAS3 SP110 DMBX1 ZFHX4 ZNF335 PITX1 KMT2A VDR | 1.05e-04 | 908 | 106 | 11 | 19274049 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.28e-04 | 363 | 106 | 7 | 14691545 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TCOF1 GEMIN5 ICE1 BTAF1 AKAP12 CEP170 ALMS1 EIF4G2 FAM169A KMT2A PCM1 | 1.35e-04 | 934 | 106 | 11 | 33916271 |
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 20353833 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 31184779 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 30584065 | ||
| Pubmed | TCEA1 PDS5B NR2C2 LCORL CEP170 BPTF GTF3C1 PITX1 EIF4G2 KMT2A SLBP PCM1 | 1.39e-04 | 1103 | 106 | 12 | 34189442 | |
| Pubmed | 1.49e-04 | 87 | 106 | 4 | 12465718 | ||
| Pubmed | 1.54e-04 | 34 | 106 | 3 | 12878157 | ||
| Pubmed | 1.58e-04 | 503 | 106 | 8 | 16964243 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NR2C2 RNF169 TCOF1 NOC2L BRCC3 SP110 BPTF GTF3C1 OSBPL3 PITX1 EIF4G2 KMT2A MPHOSPH8 | 1.59e-04 | 1294 | 106 | 13 | 30804502 |
| Pubmed | TCOF1 TRIOBP FYCO1 AKAP12 MAPK8IP3 CEP170 FXR1 GPR158 OSBPL3 PCM1 SPATA13 | 1.76e-04 | 963 | 106 | 11 | 28671696 | |
| Pubmed | Expression of melanoma-associated antigens in oral squamous cell carcinoma. | 1.91e-04 | 7 | 106 | 2 | 18197853 | |
| Pubmed | 2.55e-04 | 8 | 106 | 2 | 14563843 | ||
| Pubmed | 2.55e-04 | 8 | 106 | 2 | 28209736 | ||
| Pubmed | 2.55e-04 | 100 | 106 | 4 | 10048485 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.58e-04 | 184 | 106 | 5 | 32908313 | |
| Pubmed | 2.75e-04 | 102 | 106 | 4 | 11214970 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | TRIOBP GEMIN5 TBC1D8B CEP170 FXR1 EIF4G2 AKAP13 MPHOSPH8 PCM1 | 3.01e-04 | 701 | 106 | 9 | 30196744 |
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 3.11e-04 | 43 | 106 | 3 | 34672947 | |
| Pubmed | 3.19e-04 | 106 | 106 | 4 | 18654987 | ||
| Pubmed | 3.27e-04 | 9 | 106 | 2 | 20087947 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.96e-04 | 202 | 106 | 5 | 33005030 | |
| Pubmed | 4.05e-04 | 47 | 106 | 3 | 15172686 | ||
| Pubmed | 4.08e-04 | 10 | 106 | 2 | 28118078 | ||
| Pubmed | 4.08e-04 | 10 | 106 | 2 | 17329413 | ||
| Pubmed | RALGAPA1 MBP GEMIN5 MAPK8IP3 CEP170 NWD2 FXR1 FGD4 VCAN EIF4G2 LRRCC1 KMT2A PCM1 | 4.18e-04 | 1431 | 106 | 13 | 37142655 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 4.34e-04 | 444 | 106 | 7 | 34795231 | |
| Pubmed | 4.58e-04 | 49 | 106 | 3 | 31762063 | ||
| Pubmed | 4.63e-04 | 209 | 106 | 5 | 36779422 | ||
| Pubmed | TCEA1 PEX1 GEMIN5 FRYL AKAP12 FXR1 OSBPL3 VCAN EIF4G2 ANKRD12 SLX4 | 4.80e-04 | 1084 | 106 | 11 | 11544199 | |
| Pubmed | RNF169 NOC2L CEP170 DLC1 FGD4 EIF4G2 KMT2A COBL AKAP13 SPATA13 | 4.99e-04 | 916 | 106 | 10 | 32203420 | |
| Pubmed | TTC28 TCOF1 TRIOBP BRCC3 MAPK8IP3 OTOF EIF4G2 NAV3 LRRCC1 RNF216 SLX4 PCM1 | 5.53e-04 | 1285 | 106 | 12 | 35914814 | |
| Pubmed | 5.81e-04 | 335 | 106 | 6 | 15741177 | ||
| Pubmed | Autophagy promotes primary ciliogenesis by removing OFD1 from centriolar satellites. | 5.95e-04 | 12 | 106 | 2 | 24089205 | |
| Pubmed | 5.95e-04 | 12 | 106 | 2 | 10457012 | ||
| Pubmed | MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program. | 5.95e-04 | 12 | 106 | 2 | 27462455 | |
| Pubmed | 5.95e-04 | 12 | 106 | 2 | 32976762 | ||
| Pubmed | 6.46e-04 | 225 | 106 | 5 | 12168954 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | RIN3 LCORL ICE1 SP110 AKAP12 BPTF GTF3C1 ACSBG1 SEMA5B LPXN EDRF1 | 6.47e-04 | 1124 | 106 | 11 | 21900206 |
| Pubmed | 6.70e-04 | 129 | 106 | 4 | 23563607 | ||
| Pubmed | 7.02e-04 | 13 | 106 | 2 | 26297806 | ||
| Pubmed | 7.71e-04 | 234 | 106 | 5 | 36243803 | ||
| Pubmed | TCOF1 NOC2L BTAF1 FXR1 DLC1 GTF3C1 EIF4G2 FAM169A SLBP CDH18 | 7.81e-04 | 971 | 106 | 10 | 33306668 | |
| Pubmed | The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. | 8.18e-04 | 14 | 106 | 2 | 8575766 | |
| Pubmed | 8.18e-04 | 14 | 106 | 2 | 20196868 | ||
| Pubmed | Class III myosins shape the auditory hair bundles by limiting microvilli and stereocilia growth. | 8.18e-04 | 14 | 106 | 2 | 26754646 | |
| Pubmed | 8.44e-04 | 360 | 106 | 6 | 33111431 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 8.56e-04 | 361 | 106 | 6 | 30344098 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 8.56e-04 | 361 | 106 | 6 | 26167880 | |
| Pubmed | 8.64e-04 | 650 | 106 | 8 | 38777146 | ||
| Interaction | YWHAH interactions | RALGAPA1 RIN3 TTC28 COBLL1 BRCC3 FRYL INPP5F CEP170 CCNF FXR1 ALMS1 OSBPL3 KMT2A COBL NHS AKAP13 MARCHF4 EDRF1 PCM1 SPATA13 | 6.50e-07 | 1102 | 103 | 20 | int:YWHAH |
| Interaction | H3C3 interactions | PDS5B NR2C2 RNF169 MIS18BP1 LCORL BPTF GTF3C1 PITX1 FAM169A KMT2A MPHOSPH8 SENP7 | 8.51e-06 | 495 | 103 | 12 | int:H3C3 |
| Interaction | YWHAG interactions | RALGAPA1 TTC28 COBLL1 BRCC3 FRYL INPP5F CEP170 CCNF FXR1 DLC1 ALMS1 OSBPL3 KMT2A COBL NHS AKAP13 EDRF1 PCM1 SPATA13 | 1.63e-05 | 1248 | 103 | 19 | int:YWHAG |
| Interaction | CBX3 interactions | PDS5B NR2C2 RNF169 MIS18BP1 TCOF1 COBLL1 BTAF1 SP110 CCNF GTF3C1 KMT2A SLX4 SENP7 | 2.53e-05 | 646 | 103 | 13 | int:CBX3 |
| Cytoband | 3q12 | 5.26e-05 | 5 | 106 | 2 | 3q12 | |
| Cytoband | Xp22.13 | 1.47e-04 | 8 | 106 | 2 | Xp22.13 | |
| Cytoband | 2q24.3 | 6.20e-04 | 16 | 106 | 2 | 2q24.3 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.05e-04 | 206 | 66 | 6 | 682 | |
| GeneFamily | RAB like GTPases | 1.30e-04 | 5 | 66 | 2 | 394 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.80e-03 | 66 | 66 | 3 | 722 | |
| GeneFamily | General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated | 3.73e-03 | 25 | 66 | 2 | 565 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.32e-03 | 181 | 66 | 4 | 694 | |
| GeneFamily | PHD finger proteins | 4.35e-03 | 90 | 66 | 3 | 88 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 5.00e-03 | 29 | 66 | 2 | 396 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 5.70e-03 | 31 | 66 | 2 | 81 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 PDS5B MIS18BP1 CYBC1 MBP FRYL ICE1 BTAF1 DENND1C SP110 BIRC6 IFNAR2 BPTF LPXN EIF4G2 LPIN2 KMT2A RNF216 AKAP13 MPHOSPH8 PCM1 SPATA13 SENP7 | 1.93e-08 | 1492 | 105 | 23 | M40023 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.44e-06 | 300 | 105 | 9 | M8702 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B APPBP2 TTC28 FRYL BTAF1 INPP5F CEP170 BPTF FXR1 DLC1 FAM169A NAV3 AKAP13 MN1 | 8.25e-06 | 856 | 105 | 14 | M4500 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | MIS18BP1 TCOF1 NOC2L GEMIN5 AKAP12 CCNF UTP25 OSBPL3 VCAN LPIN2 SLBP | 2.09e-05 | 578 | 105 | 11 | M2368 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 2.65e-05 | 145 | 105 | 6 | M1810 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | MIS18BP1 TCOF1 NOC2L GEMIN5 AKAP12 CCNF UTP25 OSBPL3 VCAN LPIN2 SLBP | 2.81e-05 | 597 | 105 | 11 | MM1309 |
| Coexpression | GSE37301_PRO_BCELL_VS_CD4_TCELL_DN | 5.47e-05 | 165 | 105 | 6 | M8907 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | ABI3BP MFSD6 NPAS3 IRAK2 FASTKD2 SP110 RSC1A1 RABL2A KIAA1549L ALMS1 ZFHX4 SEMA5B PITX1 PCDH15 NAV3 LRRCC1 NHS PCM1 SENP7 | 2.11e-07 | 978 | 103 | 19 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | NR2C2 NPAS3 BTAF1 TBC1D8B RABL2A KIAA1549L ALMS1 SEMA5B FGD4 FAM169A NHS AKAP13 MPHOSPH8 ANKRD12 | 3.31e-06 | 654 | 103 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.91e-05 | 249 | 103 | 8 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | NPAS3 FRYL DMBX1 KIAA1549L ALMS1 SEMA5B FGD4 FAM169A MPHOSPH8 PCM1 SPATA13 | 3.02e-05 | 498 | 103 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | TCEA1 PDS5B TRIT1 MBP NPAS3 INPP5F CEP170 BPTF GTF3C1 ACSBG1 SEMA5B EDRF1 | 3.15e-05 | 595 | 103 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | PDS5B ABI3BP NPAS3 PCDHA11 CEP170 DLC1 ZFHX4 VCAN PITX1 COBL | 3.93e-05 | 422 | 103 | 10 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | PDS5B APPBP2 ABI3BP NPAS3 PCDHA11 AKAP12 CEP170 FXR1 DLC1 ZFHX4 VCAN PITX1 COBL SPATA13 | 4.51e-05 | 826 | 103 | 14 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.30e-05 | 271 | 103 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | MIS18BP1 ABI3BP TTC28 FYCO1 SP110 ZFHX4 ZNF827 NAV3 LRRCC1 AKAP13 ANKRD12 MARCHF4 CDH18 | 6.34e-05 | 744 | 103 | 13 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.50e-05 | 279 | 103 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | MFSD6 MBP NPAS3 BTAF1 RABL2A KIAA1549L ALMS1 ACSBG1 SEMA5B FGD4 FAM169A LRRCC1 NHS MPHOSPH8 SENP7 | 7.77e-05 | 983 | 103 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | ABI3BP MFSD6 MBP NPAS3 SP110 DMBX1 KIAA1549L ZFHX4 SEMA5B FGD4 PITX1 PCDH15 NAV3 NHS SENP7 | 7.86e-05 | 984 | 103 | 15 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | MFSD6 NPAS3 FRYL KIAA1549L ALMS1 CSRNP3 ACSBG1 SEMA5B FGD4 LPIN2 LRRCC1 NHS MPHOSPH8 SPATA13 SENP7 | 8.04e-05 | 986 | 103 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | MIS18BP1 PEX1 TRIOBP FRYL BPTF KIAA1549L ALMS1 SEMA5B FGD4 EIF4G2 LPIN2 FAM169A LRRCC1 NHS MPHOSPH8 PCM1 SPATA13 SENP7 | 9.69e-05 | 1370 | 103 | 18 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | NR2C2 MFSD6 NPAS3 FRYL TBC1D8B KIAA1549L ALMS1 CSRNP3 SEMA5B FGD4 LPIN2 MPHOSPH8 SPATA13 SENP7 | 1.04e-04 | 893 | 103 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | NR2C2 MFSD6 MBP NPAS3 TBC1D8B KIAA1549L CSRNP3 SEMA5B LPIN2 FAM169A SPATA13 SENP7 | 1.18e-04 | 683 | 103 | 12 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | ABI3BP MFSD6 NPAS3 SP110 KIAA1549L ZFHX4 SEMA5B PCDH15 NAV3 SENP7 | 1.33e-04 | 489 | 103 | 10 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.35e-04 | 231 | 103 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#1_top-relative-expression-ranked_500 | 1.37e-04 | 54 | 103 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | APPBP2 LCORL PCDHA11 ICE1 TBC1D8B CEP170 DLC1 CSRNP3 VCAN LRRCC1 | 1.40e-04 | 492 | 103 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#2 | 1.46e-04 | 103 | 103 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | PDS5B APPBP2 NPAS3 IRAK2 BIRC6 MAPK8IP3 CEP170 DLC1 ZFHX4 VCAN PITX1 COBL SPATA13 | 1.50e-04 | 811 | 103 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_200 | 1.83e-04 | 23 | 103 | 3 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | NR2C2 MFSD6 NPAS3 TBC1D8B RABL2A KIAA1549L CSRNP3 SEMA5B LPIN2 NHS AKAP13 SENP7 | 1.97e-04 | 722 | 103 | 12 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | ABI3BP TTC28 FYCO1 FASTKD2 SP110 ZFHX4 ZNF827 LRRCC1 NHS AKAP13 ANKRD12 MARCHF4 CDH18 | 1.97e-04 | 834 | 103 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | ABI3BP TTC28 TBC1D8B SP110 ZFHX4 ZNF827 NAV3 NHS AKAP13 ANKRD12 MARCHF4 CDH18 | 2.07e-04 | 726 | 103 | 12 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.08e-04 | 248 | 103 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | NR2C2 MFSD6 NPAS3 TBC1D8B KIAA1549L CSRNP3 SEMA5B FGD4 LPIN2 ANKRD12 SPATA13 SENP7 | 2.23e-04 | 732 | 103 | 12 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | ABI3BP TTC28 IRAK2 SP110 ZFHX4 ZNF827 NAV3 NHS AKAP13 ANKRD12 MARCHF4 CDH18 | 2.29e-04 | 734 | 103 | 12 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200 | 2.33e-04 | 178 | 103 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | ABI3BP MFSD6 NPAS3 TBC1D8B SP110 MAPK8IP3 KIAA1549L ZFHX4 CSRNP3 ACSBG1 SEMA5B PCDH15 NAV3 SENP7 | 2.50e-04 | 972 | 103 | 14 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | COBLL1 MFSD6 MBP NPAS3 DMBX1 KIAA1549L ZFHX4 OSBPL3 PITX1 FAM169A PCDH15 NAV3 SPATA13 SENP7 | 2.52e-04 | 973 | 103 | 14 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_100 | 2.66e-04 | 26 | 103 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_100_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_500 | 3.17e-04 | 67 | 103 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | NR2C2 MFSD6 MBP NPAS3 TBC1D8B KIAA1549L CSRNP3 SEMA5B FGD4 LPIN2 SENP7 | 3.55e-04 | 659 | 103 | 11 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#2_top-relative-expression-ranked_500 | 4.09e-04 | 30 | 103 | 3 | gudmap_developingGonad_e14.5_ ovary_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | ABI3BP TTC28 TBC1D8B AKAP12 MAPK8IP3 CEP170 ZFHX4 CSRNP3 ZNF827 ANKRD12 MN1 SENP7 | 4.50e-04 | 791 | 103 | 12 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | NR2C2 MFSD6 NPAS3 TBC1D8B KIAA1549L ALMS1 CSRNP3 SEMA5B LPIN2 PCM1 SENP7 | 5.10e-04 | 688 | 103 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.13e-04 | 288 | 103 | 7 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.62e-04 | 210 | 103 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | ABI3BP TTC28 IRAK2 SP110 ZFHX4 ZNF827 NAV3 AKAP13 MARCHF4 CDH18 | 5.99e-04 | 591 | 103 | 10 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.28e-04 | 298 | 103 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.48e-04 | 35 | 103 | 3 | gudmap_developingGonad_e14.5_ epididymis_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 6.54e-04 | 492 | 103 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | MFSD6 MBP NPAS3 KIAA1549L ACSBG1 SEMA5B FGD4 FAM169A MPHOSPH8 | 6.64e-04 | 493 | 103 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | 6.93e-04 | 496 | 103 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.31e-04 | 146 | 103 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | APPBP2 LCORL NPAS3 PCDHA11 ICE1 TBC1D8B CEP170 DLC1 ZFHX4 CSRNP3 VCAN LRRCC1 | 7.33e-04 | 836 | 103 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#5_top-relative-expression-ranked_200 | 7.64e-04 | 37 | 103 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_200_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.69e-04 | 223 | 103 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | NR2C2 MFSD6 NPAS3 TBC1D8B KIAA1549L CSRNP3 SEMA5B EIF4G2 LPIN2 SENP7 | 8.03e-04 | 614 | 103 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | ABI3BP MFSD6 NPAS3 IRAK2 TBC1D8B SP110 KIAA1549L ZFHX4 ACSBG1 SEMA5B PCDH15 NAV3 SENP7 | 8.04e-04 | 967 | 103 | 13 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.05e-04 | 225 | 103 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | ABI3BP MFSD6 NPAS3 TBC1D8B SP110 RABL2A DLC1 KIAA1549L ZFHX4 SEMA5B PCDH15 NAV3 SENP7 | 8.11e-04 | 968 | 103 | 13 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#4_top-relative-expression-ranked_500 | 8.17e-04 | 86 | 103 | 4 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | ABI3BP TTC28 FYCO1 SP110 ZFHX4 ZNF827 NAV3 NHS AKAP13 ANKRD12 MARCHF4 | 8.40e-04 | 731 | 103 | 11 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | ABI3BP MFSD6 NPAS3 SP110 KIAA1549L ZFHX4 SEMA5B FGD4 FAM169A PCDH15 NAV3 SPATA13 SENP7 | 8.75e-04 | 976 | 103 | 13 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 9.44e-04 | 232 | 103 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 9.54e-04 | 416 | 103 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | TCEA1 PDS5B TBC1D8B CEP170 BPTF KIAA1549L GTF3C1 SEMA5B FAM169A PCM1 | 9.64e-04 | 629 | 103 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#1 | 9.65e-04 | 233 | 103 | 6 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 9.68e-04 | 417 | 103 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | TCOF1 NPAS3 FRYL DMBX1 RABL2A KIAA1549L ALMS1 SEMA5B FGD4 FAM169A MPHOSPH8 PCM1 SPATA13 | 9.87e-04 | 989 | 103 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | NR2C2 MFSD6 NPAS3 TBC1D8B KIAA1549L CSRNP3 SEMA5B LPIN2 NHS AKAP13 SENP7 | 1.00e-03 | 747 | 103 | 11 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | MIS18BP1 TCOF1 BRCC3 FYCO1 SP110 ALMS1 VCAN EIF4G2 FAM169A LRRCC1 NHS ANKRD12 PCM1 SENP7 VDR | 1.02e-03 | 1252 | 103 | 15 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_100 | 1.03e-03 | 41 | 103 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_100_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#4 | 1.05e-03 | 92 | 103 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | ABI3BP TTC28 IRAK2 SP110 ADAMTS12 ZFHX4 ACSBG1 ZNF827 PCDH15 AKAP13 MARCHF4 CDH18 | 1.12e-03 | 878 | 103 | 12 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.13e-03 | 532 | 103 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | ABI3BP TTC28 FYCO1 SP110 ZFHX4 ZNF827 NAV3 NHS AKAP13 ANKRD12 | 1.26e-03 | 652 | 103 | 10 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | LCORL NPAS3 PCDHA11 CEP170 DLC1 ZFHX4 CSRNP3 VCAN PITX1 NAV3 AKAP13 | 1.26e-03 | 769 | 103 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.28e-03 | 97 | 103 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.30e-03 | 166 | 103 | 5 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 1.30e-03 | 247 | 103 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | ABI3BP TTC28 FYCO1 SP110 ZFHX4 ZNF827 NAV3 AKAP13 ANKRD12 MARCHF4 | 1.31e-03 | 655 | 103 | 10 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.33e-03 | 339 | 103 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | NR2C2 MFSD6 NPAS3 TBC1D8B KIAA1549L CSRNP3 SEMA5B LPIN2 ANKRD12 SENP7 | 1.35e-03 | 658 | 103 | 10 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#2 | 1.43e-03 | 100 | 103 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | MIS18BP1 ABI3BP FYCO1 FASTKD2 TBC1D8B RSC1A1 ADAMTS12 SEMA5B VCAN NAV3 LRRCC1 ANKRD12 MN1 SENP7 | 1.49e-03 | 1166 | 103 | 14 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_200 | 1.64e-03 | 175 | 103 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NR2C2 MIS18BP1 LCORL GEMIN5 INPP5F BIRC6 IFNAR2 CSRNP3 ADGRG2 ANKRD12 SENP7 | 1.75e-03 | 801 | 103 | 11 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.76e-03 | 567 | 103 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.18e-09 | 200 | 105 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.39e-07 | 197 | 105 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.70e-07 | 199 | 105 | 7 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.25e-06 | 171 | 105 | 6 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-06 | 174 | 105 | 6 | 6987fe7959afce347282f632abc16d800ccab7c4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.37e-06 | 180 | 105 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.37e-06 | 180 | 105 | 6 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.96e-06 | 184 | 105 | 6 | 4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.61e-06 | 188 | 105 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 189 | 105 | 6 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 5.96e-06 | 190 | 105 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-06 | 192 | 105 | 6 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 6.33e-06 | 192 | 105 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.92e-06 | 195 | 105 | 6 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 6.92e-06 | 195 | 105 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-06 | 196 | 105 | 6 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.12e-06 | 196 | 105 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 7.33e-06 | 197 | 105 | 6 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 7.33e-06 | 197 | 105 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 7.33e-06 | 197 | 105 | 6 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 7.33e-06 | 197 | 105 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.55e-06 | 198 | 105 | 6 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 7.55e-06 | 198 | 105 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.55e-06 | 198 | 105 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.77e-06 | 199 | 105 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.77e-06 | 199 | 105 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.04e-05 | 140 | 105 | 5 | 276b3fa924176426efb31112ed4d355407f0b218 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.03e-05 | 152 | 105 | 5 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 3.65e-05 | 158 | 105 | 5 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.31e-05 | 171 | 105 | 5 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.09e-05 | 176 | 105 | 5 | a31d7532f8c055d4e62bbaa78d819f2495bfee00 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.09e-05 | 176 | 105 | 5 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.26e-05 | 177 | 105 | 5 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-05 | 177 | 105 | 5 | b8de0fc92691a6d6759c743195b11edd2d63f265 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.77e-05 | 180 | 105 | 5 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.77e-05 | 180 | 105 | 5 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | critical-Lymphoid-NK|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.77e-05 | 180 | 105 | 5 | 5abf778395392244daaec876f306ed7e4f388686 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.77e-05 | 180 | 105 | 5 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.95e-05 | 181 | 105 | 5 | e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.14e-05 | 182 | 105 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.51e-05 | 184 | 105 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-05 | 184 | 105 | 5 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 7.71e-05 | 185 | 105 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-05 | 187 | 105 | 5 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.32e-05 | 188 | 105 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 8.32e-05 | 188 | 105 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-05 | 188 | 105 | 5 | c2c51c6526defe2600302901159b8abbb58d7595 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.32e-05 | 188 | 105 | 5 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 8.53e-05 | 189 | 105 | 5 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-05 | 189 | 105 | 5 | fcc3713e8200d51074f709f3360fb36efb0a639f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.74e-05 | 190 | 105 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.74e-05 | 190 | 105 | 5 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 8.74e-05 | 190 | 105 | 5 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.74e-05 | 190 | 105 | 5 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.96e-05 | 191 | 105 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 191 | 105 | 5 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 191 | 105 | 5 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.96e-05 | 191 | 105 | 5 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 191 | 105 | 5 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 191 | 105 | 5 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.18e-05 | 192 | 105 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 192 | 105 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 9.18e-05 | 192 | 105 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.18e-05 | 192 | 105 | 5 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.18e-05 | 192 | 105 | 5 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 9.18e-05 | 192 | 105 | 5 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 9.18e-05 | 192 | 105 | 5 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 9.41e-05 | 193 | 105 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.41e-05 | 193 | 105 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.41e-05 | 193 | 105 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 9.41e-05 | 193 | 105 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.41e-05 | 193 | 105 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.41e-05 | 193 | 105 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.41e-05 | 193 | 105 | 5 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 9.41e-05 | 193 | 105 | 5 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-05 | 194 | 105 | 5 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-05 | 194 | 105 | 5 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-05 | 194 | 105 | 5 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.64e-05 | 194 | 105 | 5 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | CV-Severe-6|Severe / Virus stimulation, Condition and Cluster | 9.64e-05 | 194 | 105 | 5 | d33be6ed1de907aeea0c2dce09796556b8efdd4e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.64e-05 | 194 | 105 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.87e-05 | 195 | 105 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 195 | 105 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 195 | 105 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 196 | 105 | 5 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 196 | 105 | 5 | 308fa54385ca34e9e590967d4553b84aad96c92f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 196 | 105 | 5 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 196 | 105 | 5 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 197 | 105 | 5 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 197 | 105 | 5 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 197 | 105 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.06e-04 | 198 | 105 | 5 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.06e-04 | 198 | 105 | 5 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CCL|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-04 | 199 | 105 | 5 | 52c06fcc112da21b1d914a896c04bde06fc756fe | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.09e-04 | 199 | 105 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-04 | 199 | 105 | 5 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.20e-06 | 171 | 104 | 8 | 7535_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 2.62e-05 | 189 | 104 | 7 | 5084_DN | |
| Drug | Harmine hydrochloride [343-27-1]; Down 200; 16uM; PC3; HT_HG-U133A | 2.71e-05 | 190 | 104 | 7 | 5855_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 3.20e-05 | 195 | 104 | 7 | 7444_DN | |
| Drug | Phenacetin [62-44-2]; Down 200; 22.4uM; PC3; HT_HG-U133A | 3.20e-05 | 195 | 104 | 7 | 3992_DN | |
| Drug | Aconitine [302-27-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 3.20e-05 | 195 | 104 | 7 | 2776_DN | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.30e-05 | 196 | 104 | 7 | 3268_DN | |
| Drug | Loracarbef [121961-22-6]; Down 200; 10.8uM; PC3; HT_HG-U133A | 3.30e-05 | 196 | 104 | 7 | 5073_DN | |
| Drug | Chlorphensin carbamate [886-74-8]; Down 200; 16.2uM; PC3; HT_HG-U133A | 3.53e-05 | 198 | 104 | 7 | 2115_DN | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; PC3; HT_HG-U133A | 3.53e-05 | 198 | 104 | 7 | 4259_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 3.53e-05 | 198 | 104 | 7 | 4729_DN | |
| Drug | Thiethylperazine malate [52239-63-1]; Down 200; 6uM; PC3; HT_HG-U133A | 3.64e-05 | 199 | 104 | 7 | 5756_DN | |
| Drug | Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 3.76e-05 | 200 | 104 | 7 | 2632_UP | |
| Disease | pulse pressure measurement | RIN3 TTC28 LCORL COBLL1 TRIOBP PCDHA11 FRYL DLC1 KIAA1549L ZFHX4 ZNF827 TTLL6 LPXN KIAA1755 AKAP13 PCM1 | 2.27e-05 | 1392 | 102 | 16 | EFO_0005763 |
| Disease | COVID-19, mortality | 2.85e-05 | 170 | 102 | 6 | EFO_0004352, MONDO_0100096 | |
| Disease | attempted suicide | 3.69e-05 | 178 | 102 | 6 | EFO_0004321 | |
| Disease | optic disc size measurement | 8.09e-05 | 205 | 102 | 6 | EFO_0004832 | |
| Disease | major depressive disorder, COVID-19 | 9.84e-05 | 26 | 102 | 3 | MONDO_0002009, MONDO_0100096 | |
| Disease | cup-to-disc ratio measurement | 1.27e-04 | 430 | 102 | 8 | EFO_0006939 | |
| Disease | squamous cell lung carcinoma, family history of lung cancer | 2.20e-04 | 85 | 102 | 4 | EFO_0000708, EFO_0006953 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.78e-04 | 364 | 102 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | body fat percentage | 2.98e-04 | 488 | 102 | 8 | EFO_0007800 | |
| Disease | hearing impairment | 3.79e-04 | 98 | 102 | 4 | C1384666 | |
| Disease | obsolete_9,10-dihome measurement | 5.23e-04 | 10 | 102 | 2 | EFO_0021572 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 7.40e-04 | 51 | 102 | 3 | cv:CN043650 | |
| Disease | eye morphology measurement | 9.79e-04 | 218 | 102 | 5 | EFO_0007858 | |
| Disease | corneal resistance factor | 9.87e-04 | 451 | 102 | 7 | EFO_0010067 | |
| Disease | revision of total hip arthroplasty | 1.05e-03 | 14 | 102 | 2 | EFO_0020973 | |
| Disease | response to carboplatin | 1.08e-03 | 58 | 102 | 3 | GO_0097328 | |
| Disease | Global developmental delay | 1.19e-03 | 133 | 102 | 4 | C0557874 | |
| Disease | Congenital total cataract | 1.38e-03 | 16 | 102 | 2 | C0266539 | |
| Disease | cognitive function measurement, self reported educational attainment | 1.49e-03 | 355 | 102 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | magnesium measurement | 1.57e-03 | 66 | 102 | 3 | EFO_0004845 | |
| Disease | upper aerodigestive tract neoplasm | 1.67e-03 | 246 | 102 | 5 | EFO_0004284 | |
| Disease | Benign Neoplasm | 1.71e-03 | 68 | 102 | 3 | C0086692 | |
| Disease | Neoplasms | 1.71e-03 | 68 | 102 | 3 | C0027651 | |
| Disease | synophrys measurement | 1.71e-03 | 68 | 102 | 3 | EFO_0007906 | |
| Disease | Nuclear non-senile cataract | 1.75e-03 | 18 | 102 | 2 | C1112705 | |
| Disease | Nuclear cataract | 1.75e-03 | 18 | 102 | 2 | C0392557 | |
| Disease | S-6-hydroxywarfarin measurement | 1.78e-03 | 368 | 102 | 6 | EFO_0803326 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.85e-03 | 801 | 102 | 9 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | colorectal cancer, inflammatory bowel disease | 1.95e-03 | 19 | 102 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | intraocular pressure measurement | 1.97e-03 | 509 | 102 | 7 | EFO_0004695 | |
| Disease | Deaf Mutism | 2.16e-03 | 20 | 102 | 2 | C4082305 | |
| Disease | COVID-19, osteoarthritis | 2.16e-03 | 20 | 102 | 2 | MONDO_0005178, MONDO_0100096 | |
| Disease | Deafness, Acquired | 2.16e-03 | 20 | 102 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 2.16e-03 | 20 | 102 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 2.16e-03 | 20 | 102 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 2.16e-03 | 20 | 102 | 2 | C3665473 | |
| Disease | Prelingual Deafness | 2.16e-03 | 20 | 102 | 2 | C0011052 | |
| Disease | osteoarthritis, knee | 2.24e-03 | 158 | 102 | 4 | EFO_0004616 | |
| Disease | Nonsyndromic genetic hearing loss | 2.35e-03 | 76 | 102 | 3 | cv:C5680182 | |
| Disease | bone density, lean body mass | 2.38e-03 | 21 | 102 | 2 | EFO_0003923, EFO_0004995 | |
| Disease | sensory peripheral neuropathy, remission | 2.86e-03 | 23 | 102 | 2 | EFO_0009785, MONDO_0002321 | |
| Disease | brain measurement, neuroimaging measurement | 3.03e-03 | 550 | 102 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | neuroimaging measurement, brain volume measurement | 3.20e-03 | 286 | 102 | 5 | EFO_0004346, EFO_0006930 | |
| Disease | Deafness | 3.37e-03 | 25 | 102 | 2 | C0011053 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSDDPSVTLELSQLS | 211 | P11473 | |
| DNSISPESDVDTAST | 926 | Q5SW79 | |
| PASIATNLVEESSTE | 326 | Q96KC9 | |
| SETSNPEDLIQTSST | 2006 | Q9NR09 | |
| QPNESTETTESLEVT | 1466 | P13611 | |
| SSESNLEELTQPTES | 151 | Q02952 | |
| VSQLTDSPDTTEEAT | 1006 | Q02952 | |
| TPEVETTSLNDVTLS | 66 | Q8IZP9 | |
| DPQRLSSSEETESTQ | 326 | Q12802 | |
| LSSDAVTQITTESPE | 3196 | Q8TCU4 | |
| EESELLTDTTTNILS | 3741 | Q8TCU4 | |
| ALEDVSTSPQSTEEV | 556 | Q92624 | |
| SVNPSSVDENIDSET | 321 | Q6UB98 | |
| ESDQEVTSPSQSSTA | 646 | Q8IV53 | |
| TSSPITSEEESNLSN | 1671 | Q12830 | |
| TAIQTEDSAISESPE | 776 | Q53SF7 | |
| SLSIQPSEENVSSSD | 1096 | P58397 | |
| SDTLSSAEENEPSQA | 106 | Q96B23 | |
| SPITVSDSTESNEAT | 1701 | Q9ULI1 | |
| AESPESSAIESTQST | 1356 | Q9NTI5 | |
| TSEIQPEDQSASEIT | 296 | P49116 | |
| DSNLDVTNSVPEDLS | 1196 | Q9UPP5 | |
| EQSSSIETPSEEVAS | 211 | Q9UBK7 | |
| EQSSSIETPSEEAAS | 211 | Q9UNT1 | |
| DTNDNSPEVAVTSLS | 341 | Q9Y5I1 | |
| DPLTTENASSEILDS | 1086 | M0R2J8 | |
| SDAVNTIESQSVSPD | 431 | Q9H3H1 | |
| ATTEEQEAVSSSSPL | 31 | P43359 | |
| PATEEQETASSSSTL | 31 | P43365 | |
| QSSPDLSSEESETEK | 766 | Q6P0N0 | |
| VNPSQSTEEATEATE | 886 | Q9UPT6 | |
| SSSNTPEETDDVDNS | 521 | O43187 | |
| PVSSTAEQQESSSSD | 221 | Q3B7T1 | |
| DQTEESSSLPTESQE | 826 | Q5T848 | |
| SSSLPTESQEEETTE | 831 | Q5T848 | |
| GTDSQTSLEDSPQTS | 1181 | Q5JYT7 | |
| TNSELSNPSETESER | 401 | P51114 | |
| DSLDPNAAEQDTTST | 1306 | Q9BQS8 | |
| NAAEQDTTSTSLTPE | 1311 | Q9BQS8 | |
| DSDSITVSEQSEPSA | 2686 | Q2LD37 | |
| LDSSQSTPTEELSSQ | 106 | Q8N3X6 | |
| TEVPDSAQTSNTDTT | 326 | P25089 | |
| VTDSSTQSLAPSESD | 356 | Q8WYN3 | |
| NSELTPSESLATTDD | 1456 | Q15154 | |
| SDTLDNISTDDLNTT | 891 | Q8IVL0 | |
| SSDTSIQASEPLLDT | 111 | Q96M96 | |
| PSLNLTNQEDTDESS | 2476 | O94915 | |
| ETETPQSSTVDSQDE | 871 | P63132 | |
| DETSEILSIQDNTSP | 41 | O60711 | |
| ESSQDSLVQSETAPE | 496 | Q96QE4 | |
| SETSTLSSQPSIDEV | 1536 | Q6ZVL6 | |
| PSSESSQEANLSSQE | 336 | Q13316 | |
| VERNNSTESSEETPT | 411 | Q6ZSS7 | |
| TDSSSAPSKEQLEQE | 791 | P78344 | |
| SESESESENSPQAET | 26 | Q9Y3T9 | |
| ESPDDSSSTAQTLEL | 111 | Q53HC9 | |
| SATSTESQLIDPESE | 351 | P48551 | |
| SDSSASTSLPVEESQ | 1046 | Q16821 | |
| SSNPLLTTEEANLTE | 1621 | Q96QU1 | |
| TQTILANADTSTPTD | 1601 | Q9Y2F5 | |
| DNIPDSSSLIEETNE | 266 | O14981 | |
| VTTPTAELSSQEETL | 586 | P41002 | |
| LSLSEQSASESAPED | 181 | Q8NFW5 | |
| PISTQSITNTDSEDS | 471 | Q2WGN9 | |
| SSPSDIVSLDSQQDS | 411 | O75128 | |
| LESPTELSQSSDSEA | 166 | Q9BQA9 | |
| TLDPDTSDQTDNLTE | 616 | Q96GR2 | |
| VSENLSPNTTSSLED | 556 | Q9Y6X4 | |
| TSSSTQANIPSSEEE | 336 | Q9P2E8 | |
| PSESDELQTIQEDSA | 111 | P02686 | |
| TSVLQVTATDADDPT | 176 | Q13634 | |
| SPSVDTSTDSQASEE | 481 | Q03164 | |
| PVDSSVSSSISAEEQ | 2906 | Q03164 | |
| PSSEILNDSISTQDL | 296 | Q92681 | |
| SNETQSESTEQTPSR | 996 | Q9Y2H2 | |
| TESNENESEIPVDSS | 226 | O43933 | |
| NESEIPVDSSSVASL | 231 | O43933 | |
| SDSDQQSETKEDTSP | 136 | Q99549 | |
| EIVDTSNPELTSSTE | 576 | Q9HC10 | |
| EVLLSPSSSENEISD | 456 | Q9H4L5 | |
| STSSTEEELEQFSSP | 551 | Q8TB24 | |
| EDEVSSSSDNPQALV | 1056 | Q10571 | |
| SSQLEAQEPKSSEST | 81 | A8MW99 | |
| EPLENSASESSDTEL | 41 | P78337 | |
| SDSESDSESEPQQVS | 56 | Q68CQ4 | |
| QSDSLPSTSVDSLET | 131 | Q9BQF6 | |
| ESAESSSEPQTSSQD | 216 | Q14493 | |
| AEPSANTTLVSETEE | 161 | Q13428 | |
| PESSESQTSQSESRA | 981 | Q6T4R5 | |
| QVLPLSDVDTTSATD | 616 | Q9NYY8 | |
| ENDVLTNPISEETTT | 86 | Q6UW49 | |
| ESTSPSLLTTDNTLE | 246 | Q8IXF0 | |
| PLETQNQSSEDSETE | 136 | Q9NWF9 | |
| TSQNSPEAREESTSS | 96 | P23193 | |
| SVSPESNDSISEELN | 366 | Q8NCN4 | |
| TSSQQSDEILSESPS | 161 | Q9HB58 | |
| DQDIENALSTSSSPS | 366 | Q96QB1 | |
| VNLSSDTESTDLPSS | 411 | Q96QB1 | |
| QQETSRASSTQEDTP | 306 | Q9H2D6 | |
| LDSDSEDESQSSQPL | 1606 | Q8IY92 | |
| EISPEQLSAASTEAE | 91 | P46736 | |
| NQEELSENSSSTPSE | 206 | Q96N96 | |
| DLSSENELASTVSTP | 2696 | Q86UP3 | |
| TEPEQSHSNTSTLTE | 361 | Q6GYQ0 | |
| SESTEPSDNFEVQSL | 406 | Q0IIM8 | |
| SVEPSQQLDTASTEE | 1311 | Q8TEQ6 | |
| QQLDTASTEETDPET | 1316 | Q8TEQ6 | |
| ETETPQSSTVDSQDE | 871 | P63133 | |
| LSSSQDVSSEPSSEQ | 81 | Q9P283 | |
| DSSLNQEAPTEEASS | 566 | Q8N841 | |
| LEDRIQEQSTSPDTS | 56 | Q17R98 | |
| TETDSTVKSQEESNP | 2141 | Q96AY4 | |
| TLEETDQSTQEPFTT | 621 | Q7Z7G0 | |
| DSLLDTSSVSEPNVS | 551 | Q12789 | |
| SQEEVSESSSSADPL | 66 | Q9H4Z2 | |
| TPQLTSESSDTEDSA | 1046 | Q96J92 | |
| PSQSSDISHVLETET | 131 | Q92539 | |
| NLVSSDSPLNISEDE | 226 | Q9C099 |